Background Although solely topical treatment often suffices, patients with psoriasis may
require more intensive treatment (phototherapy and/or systemic treatments) to control their …

Methods In this case series, data were collected on patients≤ 18 years old with moderate-to-
severe psoriasis treated with systemic medications (traditional systemic drugs or biologics) …

Abstract Background/Objectives Systemic medications and phototherapy are used to treat
pediatric psoriasis, but real‐world data on treatment utilization and persistence are limited …

Importance Use of systemic therapies for moderate to severe psoriasis in children is
increasing, but comparative data on their use and toxicities are limited. Objective To assess …

DEAR EDITOR, Psoriasis is a common, chronic, systemic inflammatory disease mediated by
T lymphocytes. 1 The main clinical presentation is plaque psoriasis. 2 The incidence of …

Background The decision of when to discontinue systemic treatment after achieving
remission in psoriasis is an important question. In this systematic review, we sought to …

Background There is a low rate of systemic treatment usage in moderate to severe psoriasis.
Objectives The primary objective of the present study was to assess the time period between …

Background The persistence and effectiveness of systemic therapies for moderate‐to‐
severe psoriasis in current clinical practice are poorly characterized. Objectives To …

Background Psoriasis is increasingly treated with systemic medications, yet their safety is
not well characterized in children. Objective We sought to estimate the 6-month risk of …

1 Boehncke WH, Schon MP. Psoriasis. Lancet 2015; 386: 983–94. 2 Cramer JA, Roy A,
Burrell A et al. Medication compliance and persistence: terminology and definitions. Value …